Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Yixintang Pharmaceutical Group (002727 CH)
Watchlist
29
Analysis
Consumer Staples
•
China
Yixintang Pharmaceutical Group Co., Ltd. operates pharmaceutical stores. The Company retails Chinese medicines, western medicines, and other products. Yixintang Pharmaceutical Group also provides medical equipment.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JD Health International
•
27 Jun 2022 08:45
JD Health (6618.HK) - Logic Change Due to the New Policy?
The policy about online drug sales on third-party digital platforms will add uncertainties on JD Health.Before new growth point emerges,...
Xinyao (Criss) Wang
Follow
391 Views
Share
bearish
•
Beijing Yuanxin Technology Group Co Ltd
•
17 Jun 2022 09:07
Pre-IPO Beijing Yuanxin Technology Group - Conservative About the Outlook
Yuanxin is more of a traditional offline drugstores than a healthcare technology company. The fierce competition/homogeneous business model/weak...
Xinyao (Criss) Wang
Follow
564 Views
Share
bearish
•
Medbanks Network Technology
•
27 Jan 2022 09:16
Pre-IPO Medbanks Network Technology - Conservative About the Outlook
We analyzed the business logic, concerns and outlook of Medbanks's three business lines PRS, PBM and PPS. The low margin, fierce competition and...
Xinyao (Criss) Wang
Follow
246 Views
Share
bearish
•
Dingdang Health Technology Gro
•
27 Jul 2021 09:09
Pre-IPO Dingdang Health Technology - The Future Looks Challenging
The article mainly analyzed the concerns that worth the investors' attention about Dingdang Health in terms of fierce competition, financial...
Xinyao (Criss) Wang
Follow
271 Views
Share
bearish
•
Chengdu Quanyuantang Pharmacy Chain
•
12 Jul 2021 09:10
Pre-IPO Quanyuantang Pharmacy Chain - Can Quanyuantang Find Its Own Place in the Fierce Competition?
This article mainly analyzed Quanyuantang in terms of the industry characteristics, the business, the comparison with peers, the concerns and the...
Xinyao (Criss) Wang
Follow
183 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x